Pharmaceutical Services Unit Essential Medicines Management Mo H

  • Slides: 21
Download presentation
Pharmaceutical Services Unit Essential Medicines Management Mo. H Procurement of Essential Medicines Presented by

Pharmaceutical Services Unit Essential Medicines Management Mo. H Procurement of Essential Medicines Presented by Mildred Mulenga Pharmacist, Mo. H 1

Pharmaceutical Services Unit Essential Medicines Management Outline: �Objectives �Mo. H Budget for EMs �Procurement

Pharmaceutical Services Unit Essential Medicines Management Outline: �Objectives �Mo. H Budget for EMs �Procurement Cycle �Factors that influence medicines prices �Overview of Procurement Methods �Good Pharmaceutical Procurement Practices �Organization and Management of Procurement Unit 2

Pharmaceutical Services Unit Essential Medicines Management Objectives: �To present the Mo. H Medicines Budget

Pharmaceutical Services Unit Essential Medicines Management Objectives: �To present the Mo. H Medicines Budget �To describe the procurement cycle for EMs �To present an overview of Mo. H Procurement Systems 3

Pharmaceutical Services Unit Essential Medicines Management Introduction �Pharmaceutical procurement system is major determinant of

Pharmaceutical Services Unit Essential Medicines Management Introduction �Pharmaceutical procurement system is major determinant of availability and total health costs �GRZ Medicines budget is K 590 million (per capita ZMW 47. 20) � 18. 4 % of total GRZ Health budget 4

Pharmaceutical Services Unit, DCCDs National Essential Medicines Budget Objectives q ↑ availability and accessibility

Pharmaceutical Services Unit, DCCDs National Essential Medicines Budget Objectives q ↑ availability and accessibility to all EMs and medical supplies in all health facilities 5

Pharmaceutical Services Unit, DCCDs National Essential Medicines Budget Key Strengths for 2013: q 112%

Pharmaceutical Services Unit, DCCDs National Essential Medicines Budget Key Strengths for 2013: q 112% ↑ increase of drug budget from ZMK 270 Billion (2012) to ZMK 594 billion q 248% ↑ for ARVs & 20% increase for EMs, TB, Laboratory, RHCs kits, vaccines, Cancer, Blood Products and 540% ↑ for medical supplies. q ZMK 120 Billion for ACTs 6

Pharmaceutical Services Unit, DCCDs 2013 Budget Key Issues: q ZMK 28 Billion for medical

Pharmaceutical Services Unit, DCCDs 2013 Budget Key Issues: q ZMK 28 Billion for medical and surgical supplies still inadequate in view of the high cost centers of imaging, sutures, implants, and renal consumables q New products ACTs under GRZ budget need identification of reliable and consistent supply sources q Huge medicine budget require timely procurement processes to ↑ budget absorption rates and lead times ↓ 7

Pharmaceutical Services Unit, DCCDs 2013 Budget Key Implementation Plan Issues q Need for timely

Pharmaceutical Services Unit, DCCDs 2013 Budget Key Implementation Plan Issues q Need for timely procurements of all supplies under Yellow Book q Regular review of EMLs to improve selection q Implement all supply chain strengthening activities to improve availability of Ems q Implement all rational use of medicines activities as planned 8

16. 1 19. 3 40 20 Blood Transfusion Commodities (↑ 20%) Medical and Surgical

16. 1 19. 3 40 20 Blood Transfusion Commodities (↑ 20%) Medical and Surgical Supplies (↑ 540%) Cancer Drugs (↑ 20%) Laboratory Reagents (↑ 20%) Hospital Essential Medicines (↑ 20%) Anti-Retroviral Drugs (↑ 248%) ACTs (↑ 20%) Vaccines and Immunization Supplies Tuberculosis Drugs (↑ 20%) RH Commodities (↑ 20%) 0 28. 8 60 4. 5 80 10. 0 12. 0 140 5. 4 6. 5 120. 0 160 6. 2 7. 4 8. 9 25. 8 31. 0 50. 2 100 District Essential Medicines (↑ 20%) 2012 2013 76. 2 91. 5 120 78. 0 93. 6 2012/2013 National Medicines Budget 180 9

Pharmaceutical Services Unit, DCCDs 2012 National Essential Medicines Budget District Essential Medicines 28% Hospital

Pharmaceutical Services Unit, DCCDs 2012 National Essential Medicines Budget District Essential Medicines 28% Hospital Essential Medicines 27% Blood Transfusion Commodities 6% Medical and Surgical Supplies 2% Cancer Medicines 4% Laboratory Supplies 2% Reproductive Health Commodities ARVs 2% 18% TB Medicines 3% Vaccines ACTs 9% 0% 10

Pharmaceutical Services Unit, DCCDs Hospital Essential Medicines 15% District Essential Medicines 16% Cancer Medicines

Pharmaceutical Services Unit, DCCDs Hospital Essential Medicines 15% District Essential Medicines 16% Cancer Medicines 2% Laboratory Supplies 1% Reproductive Health Commodities 1% TB Medicines 1% Vaccines 5% ACTs 20% Medical and Surgical Supplies 5% Blood Transfusion Commodities 3% 2013 National Essential Medicines Budget ARVs 29% 11

Pharmaceutical Services Unit Essential Medicines Management 2013 National ARV Drug Budget US$35 m ,

Pharmaceutical Services Unit Essential Medicines Management 2013 National ARV Drug Budget US$35 m , 25% US$45, 4 m 33% USG GF GRZ US$58, 3 m, 42% 12

Pharmaceutical Services Unit Essential Medicines Management Features of Effective Procurement Process �procure right medicines

Pharmaceutical Services Unit Essential Medicines Management Features of Effective Procurement Process �procure right medicines �high quality �lowest possible price �timely delivery �Transparent & written procedures �separation of key functions �Reliable payment & good financial management �Product quality assurance programme �Performance monitoring 13

Pharmaceutical Services Unit Essential Medicines Management Mo. H Procurement Cycle �Review medicines selection �Quantification

Pharmaceutical Services Unit Essential Medicines Management Mo. H Procurement Cycle �Review medicines selection �Quantification �Reconcile needs and budget �Select procurement method �Locate and select suppliers �Specify contract terms �Monitor order status �Receive and check medicines �Effect payment �Distribute drugs �Collect consumption data 14

Pharmaceutical Services Unit Essential Medicines Management Factors influencing Drug Prices & Total costs �Unit

Pharmaceutical Services Unit Essential Medicines Management Factors influencing Drug Prices & Total costs �Unit Prices �Purchasing models �Visible & hidden costs 15

Pharmaceutical Services Unit Essential Medicines Management Overview of Procurement Methods �Open Tender (ICB or

Pharmaceutical Services Unit Essential Medicines Management Overview of Procurement Methods �Open Tender (ICB or NCB) �Restricted Tender (closed/selective) �Competitive negotiations �Direct Procurement 16

Pharmaceutical Services Unit Essential Medicines Management Good Pharmaceutical Procurement Practices: �Procurement by Generic name

Pharmaceutical Services Unit Essential Medicines Management Good Pharmaceutical Procurement Practices: �Procurement by Generic name �NEML �Bulky procurement �Formal supplier Qualification (screening) �Competitive procurement �Orders based on reliable needs �Reliable payments 17

Pharmaceutical Services Unit Essential Medicines Management Good Pharmaceutical Procurement Prices cont. �Transparency and written

Pharmaceutical Services Unit Essential Medicines Management Good Pharmaceutical Procurement Prices cont. �Transparency and written procedures �Separation of key functions �Production quality assurance (WHO certification & post marketing surveillance) �Monitoring (auditing systems in place) 18

Pharmaceutical Services Unit Essential Medicines Management Organisation and Management of Procurement System for EMs

Pharmaceutical Services Unit Essential Medicines Management Organisation and Management of Procurement System for EMs at Mo. H �Independent unit with Head PSU �Chief Procurement Officer, Pharmaceuticals 19

Pharmaceutical Services Unit Essential Medicines Management Responsibilities in the Procurement Process �PSU �ZPPA �MTCs

Pharmaceutical Services Unit Essential Medicines Management Responsibilities in the Procurement Process �PSU �ZPPA �MTCs (Medicines and Therapeutics Committees) 20

THANK YOU FOR LISTENING. 21

THANK YOU FOR LISTENING. 21